184 related articles for article (PubMed ID: 36822164)
1. The CD16 and CD32b Fc-gamma receptors regulate antibody-mediated responses in mouse natural killer cells.
Aguilar OA; Gonzalez-Hinojosa MDR; Arakawa-Hoyt JS; Millan AJ; Gotthardt D; Nabekura T; Lanier LL
J Leukoc Biol; 2023 Jan; 113(1):27-40. PubMed ID: 36822164
[TBL] [Abstract][Full Text] [Related]
2. A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.
Vargas-Inchaustegui DA; Demberg T; Robert-Guroff M
Immunology; 2011 Nov; 134(3):326-40. PubMed ID: 21978002
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
[TBL] [Abstract][Full Text] [Related]
4. Regulation of human natural cytotoxicity by IgG. IV. Association between binding of monomeric IgG to the Fc receptors on large granular lymphocytes and inhibition of natural killer (NK) cell activity.
Sulica A; Galatiuc C; Manciulea M; Bancu AC; DeLeo A; Whiteside TL; Herberman RB
Cell Immunol; 1993 Apr; 147(2):397-410. PubMed ID: 8453679
[TBL] [Abstract][Full Text] [Related]
5. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas.
Rosario M; Liu B; Kong L; Collins LI; Schneider SE; Chen X; Han K; Jeng EK; Rhode PR; Leong JW; Schappe T; Jewell BA; Keppel CR; Shah K; Hess B; Romee R; Piwnica-Worms DR; Cashen AF; Bartlett NL; Wong HC; Fehniger TA
Clin Cancer Res; 2016 Feb; 22(3):596-608. PubMed ID: 26423796
[TBL] [Abstract][Full Text] [Related]
6. Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody.
Chen Y; You F; Jiang L; Li J; Zhu X; Bao Y; Sun X; Tang X; Meng H; An G; Zhang B; Yang L
Oncotarget; 2017 Jun; 8(23):37128-37139. PubMed ID: 28415754
[TBL] [Abstract][Full Text] [Related]
7. Factor VIII-Fc Activates Natural Killer Cells
Lagassé HAD; Hopkins LB; Jankowski W; Jacquemin MG; Sauna ZE; Golding B
Front Immunol; 2021; 12():692157. PubMed ID: 34262568
[TBL] [Abstract][Full Text] [Related]
8. Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin.
Srivastava S; Pelloso D; Feng H; Voiles L; Lewis D; Haskova Z; Whitacre M; Trulli S; Chen YJ; Toso J; Jonak ZL; Chang HC; Robertson MJ
Cancer Immunol Immunother; 2013 Jun; 62(6):1073-82. PubMed ID: 23604103
[TBL] [Abstract][Full Text] [Related]
9. Bi/tri-specific antibodies (HN-Fc-CD16 and HN-Fc-IL-15-CD16) cross-linking natural killer (NK)-CD16 and Newcastle Disease Virus (NDV)-HN, enhanced NK activation for cancer immunotherapy.
Bahrololoumi Shapourabadi M; Momburg F; Roohvand F; Jarahian M; Mohajel N; Arashkia A; Hajari Taheri F; Abbasalipour M; Azadmanesh K
Int Immunopharmacol; 2021 Jul; 96():107762. PubMed ID: 34162140
[TBL] [Abstract][Full Text] [Related]
10. Antibody Afucosylation Augments CD16-Mediated Serial Killing and IFNγ Secretion by Human Natural Killer Cells.
Karampatzakis A; Brož P; Rey C; Önfelt B; Cruz De Matos GDS; Rycroft D; Ambrose A; Davis DM
Front Immunol; 2021; 12():641521. PubMed ID: 33796107
[TBL] [Abstract][Full Text] [Related]
11. Induction of calcium flux and enhancement of cytolytic activity in natural killer cells by cross-linking of the sheep erythrocyte binding protein (CD2) and the Fc-receptor (CD16).
Anasetti C; Martin PJ; June CH; Hellstrom KE; Ledbetter JA; Rabinovitch PS; Morishita Y; Hellstrom I; Hansen JA
J Immunol; 1987 Sep; 139(6):1772-9. PubMed ID: 2957436
[TBL] [Abstract][Full Text] [Related]
12. Activation of cloned human natural killer cells via Fc gamma RIII.
Werfel T; Uciechowski P; Tetteroo PA; Kurrle R; Deicher H; Schmidt RE
J Immunol; 1989 Feb; 142(4):1102-6. PubMed ID: 2464637
[TBL] [Abstract][Full Text] [Related]
13. Anti-Gal IgG potentiates natural killer cell migration across porcine endothelium via endothelial cell activation and increased natural killer cell motility triggered by CD16 cross-linking.
Hauzenberger E; Klominek J; Holgersson J
Eur J Immunol; 2004 Apr; 34(4):1154-63. PubMed ID: 15048727
[TBL] [Abstract][Full Text] [Related]
14. A subset of CD16-natural killer cells without antibody-dependent cellular cytotoxicity function.
Schubert J; Heiken H; Jacobs R; Delany P; Witte T; Schmidt RE
Nat Immun Cell Growth Regul; 1990; 9(2):103-11. PubMed ID: 2141105
[TBL] [Abstract][Full Text] [Related]
15. Role of Fcγ receptors in HER2-targeted breast cancer therapy.
Musolino A; Gradishar WJ; Rugo HS; Nordstrom JL; Rock EP; Arnaldez F; Pegram MD
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 34992090
[TBL] [Abstract][Full Text] [Related]
16. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells.
Koyasu S
J Exp Med; 1994 Jun; 179(6):1957-72. PubMed ID: 8195719
[TBL] [Abstract][Full Text] [Related]
17. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
18. Association of the p56lck protein tyrosine kinase with the Fc gamma RIIIA/CD16 complex in human natural killer cells.
Cone JC; Lu Y; Trevillyan JM; Bjorndahl JM; Phillips CA
Eur J Immunol; 1993 Oct; 23(10):2488-97. PubMed ID: 8405050
[TBL] [Abstract][Full Text] [Related]
19. The human natural killer cytotoxic cell line NK-92, once armed with a murine CD16 receptor, represents a convenient cellular tool for the screening of mouse mAbs according to their ADCC potential.
Clémenceau B; Vivien R; Pellat C; Foss M; Thibault G; Vié H
MAbs; 2013; 5(4):587-94. PubMed ID: 23770975
[TBL] [Abstract][Full Text] [Related]
20. Agonistic effects of anti-CD2 and anti-CD16 antibodies on human natural killer killing.
Uggla CK; Geisberg M; Jondal M; Knowles RW
Scand J Immunol; 1989 May; 29(5):507-15. PubMed ID: 2567053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
